Medical Condition News

RSS

Newly engineered biomaterials could lead to possible cure for Type 1 diabetes, find researchers

Researchers have made a significant first step with newly engineered biomaterials for cell transplantation that could help lead to a possible cure for Type 1 diabetes, which affects about 3 million Americans.

10 May 2013

Research opens door to new drug therapies for Parkinson's disease

McGill University researchers have unlocked a new door to developing drugs to slow the progression of Parkinson's disease. Collaborating teams led by Dr. Edward A. Fon at the Montreal Neurological Institute and Hospital -The Neuro, and Dr. Kalle Gehring in the Department of Biochemistry at the Faculty of Medicine, have discovered the three-dimensional structure of the protein Parkin.

10 May 2013

Nicotine in peppers and tomatoes may provide protective effect against Parkinson's disease

New research reveals that Solanaceae-a flowering plant family with some species producing foods that are edible sources of nicotine-may provide a protective effect against Parkinson's disease. The study appearing today in Annals of Neurology, a journal of the American Neurological Association and Child Neurology Society, suggests that eating foods that contain even a small amount of nicotine, such as peppers and tomatoes, may reduce risk of developing Parkinson's.

9 May 2013

Neuroscientists find significant differences in brain anatomy of dyslexic people

Using MRI, neuroscientists at Georgetown University Medical Center found significant differences in brain anatomy when comparing men and women with dyslexia to their non-dyslexic control groups, suggesting that the disorder may have a different brain-based manifestation based on sex.

9 May 2013

Study: Hypersensitivity to motion may provide clues to fundamental cause of autism

Children with autism see simple movement twice as quickly as other children their age, and this hypersensitivity to motion may provide clues to a fundamental cause of the developmental disorder, according to a new study.

9 May 2013

Mathematical model with prognostic factors predicts treatment effect with bevacizumab in colorectal cancer patients

Certara-, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced that its Pharsight Consulting Services has developed a mathematical model of tumor growth inhibition, which when combined with baseline prognostic factors, predicts treatment effect with bevacizumab for patients with metastatic colorectal cancer.

9 May 2013

Loyola and Edward Hines receive award to study MBSR in women veterans at risk for heart disease

Loyola University Chicago Marcella Niehoff School of Nursing researchers and Edward Hines, Jr. VA Hospital recently were given an award to study mindfulness-based stress reduction (MBSR) in women veterans at risk for heart disease.

9 May 2013

Nearly 1/10 stroke patients suffer from chronic and debilitating pain

Nearly 1 in 10 stroke patients suffer chronic and debilitating pain, typically described as sharp, stabbing or burning. It's called central poststroke pain syndrome (CPSP). It was first described more than 100 years ago, and it is treatable with medications and magnetic or electrical stimulation of the brain.

9 May 2013

Drug resistant brain tumors: an interview with Prof. Mischel, Ludwig Institute for Cancer Research and Prof. Bensinger, University of California

In cancer, mutations in proteins that control cell growth are common, leading to unrestrained cellular proliferation and tumor formation.

9 May 2013

CEO Roundtable on Cancer recognizes efforts of Methodist Le Bonheur Healthcare

The CEO Roundtable on Cancer recently accredited Methodist Le Bonheur Healthcare with the CEO Cancer Gold Standard, recognizing the health care system's efforts to reduce the risk of cancer for their employees and covered family members by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment.

9 May 2013

European Patent Office issues notice of intent to grant patent for Nuvo Research's PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain today announced that the European Patent Office has issued a notice of Intention to Grant a European Patent that provides protection for the Company's PENNSAID 2% product.

9 May 2013

Ochsner Medical Center performs Gulf South Region's first implant of SynCardia Total Artificial Heart

When Alfred Williams was admitted to Ochsner Medical Center in December, the 41-year-old father of five had exhausted all treatment options for his enlarged heart. His condition, known as dilated cardiomyopathy, had progressed to end-stage heart failure affecting both sides of his heart. Unable to walk, he had been confined to a bed for months. Hospice care seemed like the only option Mr. Williams had left… until doctors approached him about becoming Ochsner's first patient to receive the SynCardia temporary Total Artificial Heart.

9 May 2013

Synageva BioPharma reports study results of sebelipase alfa in adults with late onset LAL Deficiency

Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare diseases, today reported 12-month results from an ongoing extension study with sebelipase alfa in adults with late onset Lysosomal Acid Lipase Deficiency.

9 May 2013

Clinical study predicting risk of near-term MI and death in CAD patients to be published in JACC

FirstMark, a division of GenWay Biotech that is focused on developing and commercializing noninvasive diagnostic and health monitoring tests for unmet clinical needs, today announced that results from the break-through proof-of-concept clinical study, performed in collaboration with Emory University and MedStar Washington Hospital Center, will be published in the Journal of the American College of Cardiology.

9 May 2013

Abbott receives CE Mark for ARCHITECT HbA1c test

Abbott today announced CE Marking (Conformité Européenne) for the ARCHITECT clinical chemistry Hemoglobin A1c test, which may aid physicians in diagnosing and monitoring diabetes as well as identifying patients at risk for developing diabetes.

9 May 2013

PCB concentrations affect both urban and rural communities, study finds

Since polychlorinated biphenyls are produced through industrial processes or activities, it is assumed that people living in industrial cities will have higher concentrations of these toxic chemicals in their blood than people in rural communities.

9 May 2013

Trevena, Forest sign collaborative agreement to develop TRV027 for treatment of ADHF

Trevena, Inc., a clinical stage pharmaceutical company and the leader in the discovery and development of G-protein coupled receptor biased ligands, and Forest Laboratories Holding Limited, a subsidiary of Forest Laboratories Inc., an international pharmaceutical company, announced today that they have entered into a collaborative licensing option agreement for the development of TRV027, an AT1R biased-ligand that recently completed Phase 2a clinical trials.

9 May 2013

Frequent use of workplace wellness center improves overall quality-of-life

People who used a workplace wellness center on frequent basis reported an improvement in their overall quality-of-life, while those that used the center less often reported no improvements in their physical quality-of-life and a decline in their mental quality-of-life, finds a new study in the American Journal of Health Promotion.

9 May 2013

Loyola opens 20-bed unit for patients undergoing stem cell transplants for cancers

Loyola University Medical Center has opened a new 20-bed unit for patients undergoing stem cell transplants for cancers such as leukemia, lymphoma and multiple myeloma.

9 May 2013

Researchers discover that microRNAs link two defining characteristics of fit muscles

Researchers discovered that small pieces of genetic material called microRNAs link the two defining characteristics of fit muscles: the ability to burn sugar and fat and the ability to switch between slow- and fast-twitch muscle fibers.

9 May 2013

Medical Condition News

Newly engineered biomaterials could lead to possible cure for Type 1 diabetes, find researchers

Research opens door to new drug therapies for Parkinson's disease

Nicotine in peppers and tomatoes may provide protective effect against Parkinson's disease

Neuroscientists find significant differences in brain anatomy of dyslexic people

Study: Hypersensitivity to motion may provide clues to fundamental cause of autism

Mathematical model with prognostic factors predicts treatment effect with bevacizumab in colorectal cancer patients

Loyola and Edward Hines receive award to study MBSR in women veterans at risk for heart disease

Nearly 1/10 stroke patients suffer from chronic and debilitating pain

Drug resistant brain tumors: an interview with Prof. Mischel, Ludwig Institute for Cancer Research and Prof. Bensinger, University of California

CEO Roundtable on Cancer recognizes efforts of Methodist Le Bonheur Healthcare

European Patent Office issues notice of intent to grant patent for Nuvo Research's PENNSAID 2%

Ochsner Medical Center performs Gulf South Region's first implant of SynCardia Total Artificial Heart

Synageva BioPharma reports study results of sebelipase alfa in adults with late onset LAL Deficiency

Clinical study predicting risk of near-term MI and death in CAD patients to be published in JACC

Abbott receives CE Mark for ARCHITECT HbA1c test

PCB concentrations affect both urban and rural communities, study finds

Trevena, Forest sign collaborative agreement to develop TRV027 for treatment of ADHF

Frequent use of workplace wellness center improves overall quality-of-life

Loyola opens 20-bed unit for patients undergoing stem cell transplants for cancers

Researchers discover that microRNAs link two defining characteristics of fit muscles

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News